Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres

By Trollet Capucine   Anvar Seyed Yahya   Venema Andrea   Hargreaves Iain P.   Foster Keith   Vignaud Alban   Ferry Arnaud   Negroni Elisa   Hourde Christophe   Baraibar Martin A.   't Hoen Peter A.C.   Davies Janet E.   Rubinsztein David C.   Heales Simon J.   Mouly Vincent   van der Maarel Silvre M.   Butler-Browne Gillian   Raz Vered   Dickson George  

Human Molecular Genetics, Vol. 19, Iss. 11, 2010-06 ,pp. : 2191-2207

Oxford University Press

Access to resources Recommend Favorite

Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy

By Hino Hirotake  

Human Molecular Genetics, Vol. 13, Iss. 2, 2004-01 ,pp. : 181-190

Oxford University Press

Access to resources Recommend Favorite

Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy

By Davies Janet E.   Rubinsztein David C.  

Human Molecular Genetics, Vol. 20, Iss. 6, 2011-03 ,pp. : 1154-1163

Oxford University Press

Access to resources Recommend Favorite

Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy

By Homma Sachiko   Beermann Mary Lou   Miller Jeffrey Boone  

Human Molecular Genetics, Vol. 20, Iss. 13, 2011-07 ,pp. : 2662-2672

Oxford University Press

Access to resources Recommend Favorite

Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy

By Abu-Baker Aida  

Human Molecular Genetics, Vol. 12, Iss. 20, 2003-10 ,pp. : 2609-2623

Oxford University Press

Access to resources Recommend Favorite